ProQR Therapeutics
PRQR
PRQR
47 hedge funds and large institutions have $31.7M invested in ProQR Therapeutics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Holders
47
Holding in Top 10
2
Calls
$880K
Puts
$69K
Top Buyers
| 1 | +$638K | |
| 2 | +$358K | |
| 3 | +$158K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$125K |
| 5 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$94K |
Top Sellers
| 1 | -$503K | |
| 2 | -$376K | |
| 3 | -$98.1K | |
| 4 |
Two Sigma Advisers
New York
|
-$80.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$44.9K |